Form D · Biotechnology

AMPLIMED CORP

Tucson, AZ · CIK 0000866105

Offering snapshot reported Mar 3, 2010 · SEC filing

Reported sold
$7.14M
Offering amount: $12M
Investors reported
11
Form D · investor count
Minimum accepted
$500
Reported outside-investor minimum
First sale
Aug 17, 2009
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$3.57M$7.14MAug 31, 2009: $3,689,043.00Aug 31, 2009Sep 22, 2009: $3,919,043.00Dec 24, 2009: $5,649,443.00Dec 24, 2009Jan 8, 2010: $6,604,443.00Mar 3, 2010: $7,142,093.00Mar 3, 2010

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$6,604,443 → $7,142,093

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Mar 3, 2010Amendment$7,142,093$537,650vs Jan 8, 201011SEC filing
Jan 8, 2010Amendment$6,604,443$955,000vs Dec 24, 200911SEC filing
Dec 24, 2009Amendment$5,649,443$1,730,400vs Sep 22, 200910SEC filing
Sep 22, 2009Amendment$3,919,043$230,000vs Aug 31, 20098SEC filing
Aug 31, 2009Initial$3,689,043No comparison8SEC filing
Apr 30, 2009Amendment$1,998,340No comparisonNot reportedSEC filing
Dec 8, 2008PaperNot reportedNo comparisonNot reportedSEC filing
Jan 4, 2008PaperNot reportedNo comparisonNot reportedSEC filing
Oct 31, 2006PaperNot reportedNo comparisonNot reportedSEC filing
Jul 15, 2005PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Not reported
Exemptions
06, 46
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$94.3K (estimated)
Form D file number
021-59001
In addition to $94,250 the Company issued DPEC Capital a total of 234,560 warrants to purchase Series D stock. The warrants issued include those issued in connection with a bridge loan, the proceeds of which were converted to shares of Series D.

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
DPEC Capital, Inc.10737

Source: Form D, filed Mar 3, 2010. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Robert T. Dorr Director, Executive
Ronald Garren Director
Harry A. George Director
John M. Holliman Director
William Reemers Executive
William Remers Executive
Chris Richied Executive
Joel Smolen Director
Randolph Steer Director
Steve Steinman Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
4380 North Campbell Avenue Suite 205
Tucson, AZ, 85718